Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study
Cancer Epidemiology · 2025
DOI: 10.1016/j.canep.2025.102864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Epidemiology, 2025. Verfasst von Jessica O'Driscoll und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland. Electronic address: jessicaodriscol20@rcsi.com. Hauptthemen laut MEDLINE: Breast Neoplasms, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Cancer Society, Health Research Board.
Abstract (Originalsprache)
BACKGROUND: This study aimed to investigate the COVID-19 impact on invasive breast cancer incidence and one-year survival in Ireland. METHODS: Anonymised aggregate population data from the National Cancer Registry Ireland were used to examine incidence between 2014 and 2020 and differences in the distribution of clinical characteristics using chi-squared tests. Negative binomial regression examined the association between incidence and year of diagnosis. One-year survival was examined by year of diagnosis using Cox proportional hazards regression modelling. RESULTS: For 2020, the age-standardised incidence rate (ASR, per 100,000 females) was 131.9, compared to 163.9 for 2019. In 2020, the incidence rate significantly declined (IRR = 0.41, 95 % CI = 0.22, 0.75) relative to 2019. Fewer cases presented through organised screening (-62.3 %), while similar or increased numbers presented with symptoms (0.1 %) and via other methods (9.0 %) respectively in 2020, compared to 2019. Significant differences were observed in case distribution by ER status (p = 0.02) and stage (p < 0.01) between 2019 and 2020. One-year survival was similar for cases diagnosed during 2014-2019 and in 2020 (HR = 1.07, 95 % CI = 0.89, 1.27). CONCLUSIONS: These findings demonstrate reductions in invasive breast cancer incidence and no difference in one-year survival following the pandemic onset. Additional studies to determine the longer-term COVID-19 impact are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland. Electronic address: jessicaodriscol20@rcsi.com.
- National Cancer Registry Ireland, Cork, Ireland.
- School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
- School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; School of Public Health, University College Cork, Cork, Ireland.
Förderung
- Irish Cancer Society
- Health Research Board
Zitieren
APA
O'Driscoll, J., Tierney, P. A., McDevitt, J., Brennan, A., Redaniel, M. T., Zhang, M., Bennett, K., Murray, D., & Mullooly, M. (2025). Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2025.102864
Vancouver
O'Driscoll J, Tierney PA, McDevitt J, Brennan A, Redaniel MT, Zhang M, et al. Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study. Cancer Epidemiology. 2025. doi:10.1016/j.canep.2025.102864
BibTeX
@article{ODriscoll2025,
author = {O'Driscoll, Jessica and Tierney, Paula A and McDevitt, Joe and Brennan, Aline and Redaniel, Maria Theresa and Zhang, Mengyang and Bennett, Kathleen and Murray, Deirdre and Mullooly, Maeve},
title = {Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study},
journal = {Cancer Epidemiology},
year = {2025},
doi = {10.1016/j.canep.2025.102864}
}
EUVIMED